Immediate Impact

2 by Nobel laureates 57 standout
Sub-graph 1 of 23

Citing Papers

Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
2024 Standout
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
2024 Standout
9 intermediate papers

Works of Mari Aso being referenced

Relationship between Programmed Cell Death Protein Ligand 1 Expression and Immune-related Adverse Events in Non-small-cell Lung Cancer Patients Treated with Pembrolizumab
2019
Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
Mari Aso 296 123 41 73 11 336
Helen Clare Dearden 306 88 31 80 13 358
Eli P. Darnell 245 160 32 90 9 385
Yael Steinberg‐Silman 298 56 48 74 8 359
Arissa Young 204 56 39 82 10 317
Meagan S. Barbee 223 87 22 78 8 315
Benjamin Benhuri 267 52 27 66 8 346
Marie-Léa Gauci 251 55 66 87 12 333
GH Tan 271 78 46 55 8 374
Keith L. Shulman 162 63 21 111 14 340
Edwin A. Basak 308 90 43 119 18 384

All Works

Loading papers...

Rankless by CCL
2026